@article{article, title  = {{A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.vaccine.2023.01.007 }},

 year = {{2023}},

 month = {{1}},

 author = {{Tricou V and Eyre S and Ramjee M and Collini P and Mojares Z and Loeliger E and Mandaric S and Rauscher M and Brose M and Lefevre I and Folschweiller N et al}},

 doi = {{10.1016/j.vaccine.2023.01.007}},

 journal = {{Vaccine}},

 note = {{Accessed on 2024/12/22}}}